Fieldpoint Private Securities’s Halozyme HALO Stock Holding History

Fieldpoint Private Securities’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$3K	Sell	60 -115	-66%	-$4.97K	﹤0.01%	1048
2022 Q1	$7K	Buy	+175	New	+$6.23K	﹤0.01%	1184
2021 Q4	–	Sell	-1,477	Closed	-$60K	–	1692
2021 Q3	$60K	Hold	1,477	–	–	0.01%	531
2021 Q2	$61K	Sell	1,477 -37	-2%	-$1.64K	0.01%	528
2021 Q1	$63K	Buy	1,514 +1,464	+2,928%	+$66.8K	0.01%	515
2020 Q4	$2K	Buy	+50	New	+$1.8K	﹤0.01%	1317

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fieldpoint Private Securities's HALO Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Halozyme (HALO) stake by 66% in Q2 2022, selling an estimated $4.97K and leaving 60 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1048.

Fieldpoint Private Securities first reported a position in HALO in Q4 2020 and has held it in 6 quarters since. The position peaked at $63K in Q1 2021. 368 funds tracked by Wall St. Rank hold HALO as of Q2 2022.

Fieldpoint Private Securities held 60 shares of Halozyme worth $3K as of Q2 2022.
Fieldpoint Private Securities sold 115 Halozyme shares in Q2 2022, an estimated $4.97K.
Halozyme made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1048 holding.
Fieldpoint Private Securities first reported a position in Halozyme in Q4 2020 and has held it in 6 quarters since.
Fieldpoint Private Securities's Halozyme position peaked at $63K in Q1 2021.
368 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.